Valeant Pharmaceuticals

Page 3 of 4

J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance

Valeant Shareholders Push for More Details About CEO’s Illness

By
March 14, 2016
NCAA Men's Final Four - Championship
Features

Fed Meeting, Valeant Earnings, and March Madness—5 Things to Know for the Week Ahead

By
March 13, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Health

Bill Ackman Just Got Himself a Board Member on Valeant

By
March 9, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance

Here’s Why Shares of Valeant Are Jumping Today

By
March 7, 2016
Hillary Clinton Holds Post-Super Tuesday Rally In NYC
Finance

This Is Why Hillary Clinton’s Attack on Drug Price Hikes Doesn’t Add Up

By
March 4, 2016
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., speaks during their annual general meeting in Laval, Quebec
Finance

Valeant Is Being Investigated by the SEC and Shares Are Plunging

By
February 29, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance

This Is Why Shares of Valeant Are Cratering Today

By
February 29, 2016
House Oversight Hearing On Prescription Drug Price Increases
Finance

Why Valeant’s Stock Surged After CEO Admitted ‘Mistakes’

By
February 23, 2016
Views From A Shoppers Drug Mart Store Ahead Of Earns
Health

Study Says This Cold Medicine Doesn’t Actually Fight Colds

By
February 1, 2016
Inside The 2016 Consumer Electronics Show
Finance

These Stock Market-Battered Execs Just Became Ex-Billionaires

By
January 26, 2016
High Oil Prices Continue To Drive Gas Prices Steadily Upwards
Health

Doomsday Postponed and Valeant’s Management Talks–5 Things to Know Today

By Laura Lorenzetti and Geoffrey Smith
January 13, 2016
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance

Valeant CEO Says Board Is ‘Welcome to Fire Me’

By
December 16, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance

Congressman Calls Out Valeant’s ‘Lack of Transparency’

By
December 16, 2015
SWITZERLAND-PHARMA-EARNINGS-COMPANY-NOVARTIS
Finance

Novartis Agrees to $390 Million Settlement

By
November 20, 2015
Why the drug price scandal won’t be enough to keep down prices
Retail

Why the drug price scandal won’t be enough to keep down prices

By
October 26, 2015

Most Popular